Anti-Aging Therapeutics Volume XVII

A4M American Academy

Description

Proceedings of the Twenty-Second World Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies, sponsored by the American Academy of Anti-Aging Medicine (A4M).

Sujets

• Medical
• Médecine
• Training
• Education

Informations

• Publié par: eBookIt.com
• Date de parution: 12 novembre 2015
• Nombre de lectures: 0
• EAN13: 9781934715192
• Langue: English
• Poids de l'ouvrage: 2 Mo

Extrait

IMPORTANT – PLEASE READ
The content presented in the Anti-Aging Therapeutics, volume 17 is for educational purposes only and is specifically designed for those with a health, medical, or biotechnological education or professional experience. Anti-Aging Therapeutics, volume 17 does not prevent, diagnose, treat or cure disease or illness.
While potentially therapeutic pharmaceuticals, nutraceuticals (dietary supplementation) and interventive therapies are described in the A4M's Anti-Aging Therapeutics, volume 17 , this work serves the sole purpose of functioning as an informational resource. Under no circumstances is the reader to construe endorsement by A4M of any specific companies or products. Quite to the contrary, Caveat Emptor. It is the reader's responsibility to investigate the product, the vendor, and the product information.
Dosing of nutraceuticals can be highly variable. Proper dosing is based on parameters including sex, age, and whether the patient is well or ill (and, if ill, whether it is a chronic or acute situation). Additionally, efficiency of absorption of a particular type of product and the quality of its individual ingredients are two major considerations for choosing appropriate specific agents for an individual's medical situation.
Furthermore, anyone with malignancy should consult their physician or oncologist prior to beginning, or continuing, any hormone therapy program.
Be mindful that just because a product is natural doesn't mean it's safe for everyone. A small portion of the general population may react adversely to components in nutraceuticals (especially herbal products). A complete inventory of interventions utilized by a patient should be maintained by physicians and health practitioners dispensing anti-aging medical care.
Views, opinions, and commentaries expressed by respective author(s) do not reflect the official policy or position of the A4M.
Anti-Aging Therapeutics, volume 17 is, again, designed for those with a health, medical, or biotechnological education or professional experience. It is not intended to provide medical advice, and is not to be used as a substitute for advice from a physician or health practitioner. If you are a consumer interested in any of the approaches discussed in these chapters, it is absolutely essential that you have a thorough discussion with your physician to understand all benefits and risks.
For those individuals interested in the diagnostics and/or therapies described by chapter authors of Anti-Aging Therapeutics, volume 17 , A4M urges that you consult a knowledgeable physician or health practitioner, preferably one who has been Board Certified in Anti-Aging Medicine. You may find one by utilizing the Anti-Aging Directory at www.a4m.com .
 
Anti-Aging Therapeutics volume 17 Copyright © 2015. American Academy of Anti-Aging Medicine.
1510 West Montana Street; Chicago IL 60614 USA.
All rights reserved.
 
Published in eBook format by A4M American Academy of Anti-Aging Medicine
Converted by http://www.eBookIt.com
 
ISBN-13: 978-1-9347-1519-2
 
 
Electronic and/or print reproduction, storage in an electronic and/or physical retrieval system, or transmission by any means (electronic, mechanical, photocopying, microfilming, recording, or otherwise) requires the advance written consent by the publisher.
Chapter 1
President’s Message: A4M at the Helm of $295 Billion Marketplace – Achievements and Future Horizons
Ronald Klatz, M.D., D.O.
President, American Academy of Anti-Aging Medicine (A4M)
 
INTRODUCTION
Historian Alan Kay remarked that: “The best way to predict the future is to invent it." The A4M demonstrates future-forward innovative thinking that has not merely withstood the tests of time and scrutiny, but has flourished and proliferated into a viable model now embraced around the world.
In 1991, a group of one dozen future-forward physicians convened to discuss the wide-ranging ramifications of rapidly emerging important discoveries towards identifying the mechanisms of deterioration and vulnerability to age-related diseases. As such, this group introduced a new definition of aging. In this new perspective, the frailties and physical and mental failures associated with normal aging are caused by physiological dysfunctions that, in many cases, can be altered by appropriate medical interventions. As an extension of this redefinition, this group proposed an innovative model for healthcare that focused on the application of advanced scientific and medical technologies for the early detection, prevention, treatment, and reversal of age-related dysfunction, disorders, and diseases. "Anti-aging medicine," and the American Academy of Anti-Aging Medicine (A4M), were born.
In the twenty-four years that have since followed, anti-aging medicine has achieved international recognition. Anti-aging medicine is now practiced by thousands of physicians in private medical offices, as well as at some of the most prestigious teaching hospitals around the world. Universally, those involved in healthcare, or those whose fields of expertise intersect with healthcare issues, support anti-aging medicine as a healthcare model promoting innovative science and research to prolong the healthy human lifespan. Public policy organizations and government agencies are now embracing anti-aging medicine as a viable solution to alleviate the mounting social, economic, and medical woes otherwise anticipated to arrive with the aging of nearly every nation on the planet.
 
OVERVIEW
As it has remained for its entire existence, the A4M is a non-profit educational medical organization dedicated to the scientific premise that diseases and disabilities of human aging are largely preventable, treatable, and perhaps even reversible. The A4M is an international body of physicians, scientists, academicians, and government- and university-affiliated officials. A4M's membership numbers 26,000 hailing from over 120 nations worldwide. A4M’s accomplishments in advancing the acceptance, availability and accessibility of anti-aging medicine worldwide are summarized in Table 1.
 
Table 1. A4M Accomplishments (partial list) Congresses: University academic co-sponsored or joint sponsored, ACCME-approved AMA and AOA-recognized continuing education for over 100,000 physicians and scientists
  Now in its 23 rd consecutive year. Started with 50 attendees in 1992, 6,000+ delegates projected for Winter 2015 conference
 
Headlining speakers have included:
• Arnold Schwarzenegger
• Suzanne Somers
• Congressman Ron Paul
• House Speaker Newt Gingrich
• Senator Orin Hatch
• J. Craig Venter Co-supported International conferences – sanctioned by Ministries of Health, in: Germany, England, Portugal, China, Japan, Indonesia, Singapore, Malaysia, Thailand, Taiwan, Australia, India, and United Arab Emirates (partial list) University affiliations:
 
• Fellowships - The Morsani College of Medicine at The University of South Florida (USF)
• Certification & Masters - The University of South Florida (USF)
• Graduate Certificate in Integrative Medicine - The George Washington University (Washington DC) Expansive Internet reach:
 
• Sponsors The World Health Network, the Internet’s leading non-commercial resource for anti-aging information
• Publishes The Longevity Magazine® eJournal, award-winning weekly newsletter featuring the latest breakthroughs in life extension and life enhancement Global media reach:
 
• Major print, tv, radio placements that raise the profile of anti-aging medicine: past placements include BBC (British Broadcast Channel), The O’Reilly Factor, Lifetime, 48 Hours, 20/20, CBS Evening News, Oprah Winfrey Show, New York Times, Los Angeles Times, Chicago Tribune, CNN, USA Today, Forbes, Business Week, Investor's Business Daily, Smart Money, WebMD and HealthScout (partial list)
• Syndicated column published in magazines in 6 countries Excellence in publishing:
 
• Publishes books for consumer audience that raise the awareness of anti-aging medicine in the general public, with over 2 million copies in-print
• Publishes titles for clinicians, researchers, government agencies, and academic institutions Videos: 2,000+ YouTube anti-aging videos by/on A4M
 
ACCOMPLISHMENTS
A4M serves as an advocate for the new clinical specialty of anti-aging medical science and acts as a conduit to physicians, scientists, and the educated public who wish to benefit from the almost daily breakthroughs in biotechnology which promise both a greater quality as well as quantity of life. The A4M is the:
• First to create the anti-aging medical movement.
• Founder of the world’s fastest-growing medical specialty.
• Leading provider of university academic co-sponsored medical education in the field.
• Recognized leadership for a $295 billion marketplace
 
Nearly 3 decades ago, the founding members of the A4M predicted the shift in the global demographics towards a worldwide greying trend, and the organization forged a model for clinical healthcare to advance preventive healthcare by applying cutting-edge diagnostic and therapeutic technologies. An array of life-enhancing, life-extending achievements for human longevity has since resulted. World-renowned speakers at the A4M’s Annual Congresses on Anti-Aging Medicine have debuted breakthrough findings that include:
 
Table 2. Preventative Medical Breakthroughs Based in Anti-Aging Science (partial list) 2015:
 
  Microbiome in brain health [Perlmutter]
  Cardiac-neurological-immune connection [Houston] 2010:
 
  Concussion in Neurodegenerative Disease [Maroon] 2007:
 
  Traumatic Brain Injury (TBI) & hormone dysregulation [Gordon] 2006:
 
  Phytonutrients for prevention of atherosclerosis [Siegel] 2005:
 
  Inflammation in neurodegenerative disorders [Perlmutter]
  Fatty acids for cardiovascular health [Rothenberg] 2003:
 
  Inflammation in cardiovascular disease [Sinatra]
  Vaccine